nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—Benazepril—MTHFR—polycystic ovary syndrome	0.0131	0.551	CrCbGaD
Solifenacin—Benazepril—ACE—polycystic ovary syndrome	0.0107	0.449	CrCbGaD
Solifenacin—Renal impairment—Metformin—polycystic ovary syndrome	0.00712	0.0477	CcSEcCtD
Solifenacin—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00626	0.0419	CcSEcCtD
Solifenacin—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00619	0.0415	CcSEcCtD
Solifenacin—Influenza—Metformin—polycystic ovary syndrome	0.00586	0.0392	CcSEcCtD
Solifenacin—Infestation NOS—Metformin—polycystic ovary syndrome	0.00523	0.035	CcSEcCtD
Solifenacin—Infestation—Metformin—polycystic ovary syndrome	0.00523	0.035	CcSEcCtD
Solifenacin—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00494	0.0331	CcSEcCtD
Solifenacin—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00462	0.0309	CcSEcCtD
Solifenacin—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00461	0.0309	CcSEcCtD
Solifenacin—Eye disorder—Metformin—polycystic ovary syndrome	0.00438	0.0294	CcSEcCtD
Solifenacin—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00435	0.0291	CcSEcCtD
Solifenacin—Angiopathy—Metformin—polycystic ovary syndrome	0.00426	0.0285	CcSEcCtD
Solifenacin—Immune system disorder—Metformin—polycystic ovary syndrome	0.00424	0.0284	CcSEcCtD
Solifenacin—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00423	0.0283	CcSEcCtD
Solifenacin—Malnutrition—Metformin—polycystic ovary syndrome	0.00408	0.0273	CcSEcCtD
Solifenacin—Dysgeusia—Metformin—polycystic ovary syndrome	0.004	0.0268	CcSEcCtD
Solifenacin—Vision blurred—Metformin—polycystic ovary syndrome	0.00385	0.0258	CcSEcCtD
Solifenacin—Palpitations—Metformin—polycystic ovary syndrome	0.00361	0.0242	CcSEcCtD
Solifenacin—Hypertension—Metformin—polycystic ovary syndrome	0.00353	0.0236	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00345	0.0231	CcSEcCtD
Solifenacin—Infection—Metformin—polycystic ovary syndrome	0.00331	0.0222	CcSEcCtD
Solifenacin—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00327	0.0219	CcSEcCtD
Solifenacin—Skin disorder—Metformin—polycystic ovary syndrome	0.00324	0.0217	CcSEcCtD
Solifenacin—Somnolence—Metformin—polycystic ovary syndrome	0.00296	0.0198	CcSEcCtD
Solifenacin—Dyspepsia—Metformin—polycystic ovary syndrome	0.00293	0.0196	CcSEcCtD
Solifenacin—Decreased appetite—Metformin—polycystic ovary syndrome	0.0029	0.0194	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00288	0.0193	CcSEcCtD
Solifenacin—Fatigue—Metformin—polycystic ovary syndrome	0.00287	0.0192	CcSEcCtD
Solifenacin—Constipation—Metformin—polycystic ovary syndrome	0.00285	0.0191	CcSEcCtD
Solifenacin—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00275	0.0184	CcSEcCtD
Solifenacin—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00272	0.0182	CcSEcCtD
Solifenacin—Urticaria—Metformin—polycystic ovary syndrome	0.00265	0.0177	CcSEcCtD
Solifenacin—Abdominal pain—Metformin—polycystic ovary syndrome	0.00263	0.0176	CcSEcCtD
Solifenacin—Asthenia—Metformin—polycystic ovary syndrome	0.00239	0.016	CcSEcCtD
Solifenacin—Pruritus—Metformin—polycystic ovary syndrome	0.00236	0.0158	CcSEcCtD
Solifenacin—Dizziness—Metformin—polycystic ovary syndrome	0.0022	0.0148	CcSEcCtD
Solifenacin—Vomiting—Metformin—polycystic ovary syndrome	0.00212	0.0142	CcSEcCtD
Solifenacin—Rash—Metformin—polycystic ovary syndrome	0.0021	0.0141	CcSEcCtD
Solifenacin—Dermatitis—Metformin—polycystic ovary syndrome	0.0021	0.0141	CcSEcCtD
Solifenacin—Headache—Metformin—polycystic ovary syndrome	0.00209	0.014	CcSEcCtD
Solifenacin—Nausea—Metformin—polycystic ovary syndrome	0.00198	0.0133	CcSEcCtD
Solifenacin—CHRM2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000197	0.000238	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000196	0.000237	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000195	0.000236	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000194	0.000235	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—INSR—polycystic ovary syndrome	0.000193	0.000233	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000191	0.000232	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000191	0.000232	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000191	0.000231	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000189	0.000229	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000188	0.000228	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PGR—polycystic ovary syndrome	0.000187	0.000226	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000186	0.000225	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000186	0.000225	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—SULT2A1—polycystic ovary syndrome	0.000184	0.000222	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000184	0.000222	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000183	0.000222	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000181	0.00022	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—FST—polycystic ovary syndrome	0.000181	0.000219	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00018	0.000218	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00018	0.000218	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00018	0.000218	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000179	0.000217	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—FST—polycystic ovary syndrome	0.000179	0.000217	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000179	0.000216	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PGR—polycystic ovary syndrome	0.000179	0.000216	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—RRM2—polycystic ovary syndrome	0.000178	0.000215	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000178	0.000215	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000178	0.000215	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000178	0.000215	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000177	0.000214	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000177	0.000214	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—LHB—polycystic ovary syndrome	0.000177	0.000214	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000175	0.000211	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000173	0.00021	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000173	0.00021	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000173	0.000209	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000173	0.000209	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—YAP1—polycystic ovary syndrome	0.000172	0.000208	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000171	0.000207	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000168	0.000203	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000167	0.000202	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000167	0.000202	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000167	0.000202	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000167	0.000202	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000166	0.000201	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000166	0.000201	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000166	0.000201	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000166	0.0002	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000165	0.0002	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—SCT—polycystic ovary syndrome	0.000165	0.0002	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000165	0.0002	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000165	0.0002	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—NAMPT—polycystic ovary syndrome	0.000165	0.0002	CbGpPWpGaD
Solifenacin—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000165	0.000199	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000164	0.000198	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000164	0.000198	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000163	0.000198	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CYP11A1—polycystic ovary syndrome	0.000163	0.000197	CbGpPWpGaD
Solifenacin—CHRM1—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000162	0.000196	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000162	0.000196	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000161	0.000195	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000161	0.000194	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00016	0.000194	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000158	0.000192	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000158	0.000192	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000158	0.000191	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000156	0.000189	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000156	0.000188	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000155	0.000188	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000155	0.000187	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000154	0.000187	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—AKR1C3—polycystic ovary syndrome	0.000154	0.000186	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000154	0.000186	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000154	0.000186	CbGpPWpGaD
Solifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000154	0.000186	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000154	0.000186	CbGpPWpGaD
Solifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000153	0.000185	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000153	0.000185	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000152	0.000184	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000152	0.000184	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000152	0.000184	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CYP17A1—polycystic ovary syndrome	0.000151	0.000183	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000151	0.000183	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PRL—polycystic ovary syndrome	0.000151	0.000183	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00015	0.000181	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000146	0.000177	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000146	0.000176	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000145	0.000176	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PRL—polycystic ovary syndrome	0.000145	0.000175	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000144	0.000174	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000144	0.000174	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000144	0.000174	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000142	0.000172	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000142	0.000172	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000142	0.000171	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.00014	0.00017	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.00014	0.00017	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00014	0.00017	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.00014	0.000169	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000137	0.000166	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000136	0.000164	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—INSR—polycystic ovary syndrome	0.000135	0.000164	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000134	0.000162	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000133	0.000161	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—TH—polycystic ovary syndrome	0.000131	0.000159	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000129	0.000156	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000129	0.000156	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—SLC2A4—polycystic ovary syndrome	0.000128	0.000154	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000127	0.000154	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000127	0.000154	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000127	0.000154	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000127	0.000153	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000127	0.000153	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000126	0.000152	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000125	0.000152	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PGR—polycystic ovary syndrome	0.000125	0.000152	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000124	0.000151	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000124	0.00015	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000121	0.000147	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CYP19A1—polycystic ovary syndrome	0.00012	0.000145	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000119	0.000144	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000118	0.000142	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000117	0.000141	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000117	0.000141	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000117	0.000141	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000117	0.000141	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000115	0.00014	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000115	0.00014	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000113	0.000136	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000112	0.000136	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000112	0.000135	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000112	0.000135	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000111	0.000135	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000111	0.000135	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00011	0.000133	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000109	0.000132	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000108	0.000131	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000108	0.000131	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000108	0.000131	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000107	0.00013	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—GNAS—polycystic ovary syndrome	0.000107	0.000129	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000107	0.000129	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000107	0.000129	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000106	0.000129	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—LEP—polycystic ovary syndrome	0.000104	0.000126	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000103	0.000125	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000103	0.000124	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000102	0.000124	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000102	0.000123	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000102	0.000123	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000102	0.000123	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—NCOR1—polycystic ovary syndrome	0.000102	0.000123	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PRL—polycystic ovary syndrome	0.000102	0.000123	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000102	0.000123	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000101	0.000122	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000101	0.000122	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—LEP—polycystic ovary syndrome	9.99e-05	0.000121	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.83e-05	0.000119	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.8e-05	0.000119	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.71e-05	0.000117	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.68e-05	0.000117	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CYP1A1—polycystic ovary syndrome	9.66e-05	0.000117	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.65e-05	0.000117	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.56e-05	0.000116	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	9.49e-05	0.000115	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IRS1—polycystic ovary syndrome	9.31e-05	0.000113	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	9.05e-05	0.000109	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—MTHFR—polycystic ovary syndrome	9.01e-05	0.000109	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	8.98e-05	0.000109	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—POMC—polycystic ovary syndrome	8.96e-05	0.000108	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—GNAS—polycystic ovary syndrome	8.95e-05	0.000108	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—INS—polycystic ovary syndrome	8.91e-05	0.000108	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IRS1—polycystic ovary syndrome	8.91e-05	0.000108	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	8.86e-05	0.000107	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IGF1—polycystic ovary syndrome	8.62e-05	0.000104	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—AKT2—polycystic ovary syndrome	8.62e-05	0.000104	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—POMC—polycystic ovary syndrome	8.58e-05	0.000104	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.55e-05	0.000103	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—INS—polycystic ovary syndrome	8.54e-05	0.000103	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.52e-05	0.000103	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.44e-05	0.000102	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	8.39e-05	0.000102	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NRG1—polycystic ovary syndrome	8.37e-05	0.000101	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	8.29e-05	0.0001	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IGF1—polycystic ovary syndrome	8.26e-05	9.99e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	8.25e-05	9.98e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—AKT2—polycystic ovary syndrome	8.25e-05	9.98e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.19e-05	9.9e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	8.07e-05	9.76e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.84e-05	9.48e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	7.81e-05	9.45e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PPARG—polycystic ovary syndrome	7.31e-05	8.84e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—POMC—polycystic ovary syndrome	7.2e-05	8.71e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	7.19e-05	8.7e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	7.19e-05	8.7e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IRS2—polycystic ovary syndrome	7.17e-05	8.67e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—INS—polycystic ovary syndrome	7.16e-05	8.67e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	7.1e-05	8.58e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	7.04e-05	8.51e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—LEP—polycystic ovary syndrome	7.01e-05	8.48e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	6.96e-05	8.42e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	6.94e-05	8.4e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	6.71e-05	8.12e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—IL6—polycystic ovary syndrome	6.59e-05	7.97e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	6.45e-05	7.8e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	6.37e-05	7.7e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—IL6—polycystic ovary syndrome	6.31e-05	7.64e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	6.28e-05	7.59e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IRS1—polycystic ovary syndrome	6.26e-05	7.57e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	6.2e-05	7.49e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	6.04e-05	7.31e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—POMC—polycystic ovary syndrome	6.02e-05	7.29e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	6.02e-05	7.28e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	6.01e-05	7.27e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—INS—polycystic ovary syndrome	5.99e-05	7.25e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	5.97e-05	7.22e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	5.93e-05	7.18e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	5.92e-05	7.16e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	5.81e-05	7.03e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	5.81e-05	7.03e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IGF1—polycystic ovary syndrome	5.79e-05	7.01e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—AKT2—polycystic ovary syndrome	5.79e-05	7e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	5.74e-05	6.94e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	5.73e-05	6.94e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.63e-05	6.81e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.52e-05	6.68e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.5e-05	6.66e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.45e-05	6.59e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.39e-05	6.52e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—TH—polycystic ovary syndrome	5.12e-05	6.2e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	4.98e-05	6.03e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	4.69e-05	5.67e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	4.45e-05	5.38e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL6—polycystic ovary syndrome	4.43e-05	5.36e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	4.39e-05	5.31e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.18e-05	5.06e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.98e-05	4.82e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL6—polycystic ovary syndrome	3.89e-05	4.71e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.8e-05	4.59e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.79e-05	4.58e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.78e-05	4.57e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.75e-05	4.53e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL6—polycystic ovary syndrome	3.73e-05	4.51e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.52e-05	4.26e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.86e-05	3.45e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.82e-05	3.41e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.8e-05	3.39e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	2.63e-05	3.18e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL6—polycystic ovary syndrome	2.62e-05	3.17e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	2.59e-05	3.14e-05	CbGpPWpGaD
